Aardvark Therapeutics Statistics
Total Valuation
AARD has a market cap or net worth of $211.09 million. The enterprise value is $129.60 million.
Important Dates
Earnings Date | n/a |
Ex-Dividend Date | n/a |
Share Statistics
AARD has 27.27 million shares outstanding. The number of shares has increased by 2.06% in one year.
Current Share Class | 27.27M |
Shares Outstanding | 27.27M |
Shares Change (YoY) | +2.06% |
Shares Change (QoQ) | +0.49% |
Owned by Insiders (%) | 11.53% |
Owned by Institutions (%) | 8.06% |
Float | 18.03M |
Valuation Ratios
PE Ratio | n/a |
Forward PE | n/a |
PS Ratio | n/a |
Forward PS | n/a |
PB Ratio | 2.62 |
P/TBV Ratio | n/a |
P/FCF Ratio | n/a |
P/OCF Ratio | n/a |
PEG Ratio | n/a |
Financial Ratio History Enterprise Valuation
EV / Earnings | n/a |
EV / Sales | n/a |
EV / EBITDA | n/a |
EV / EBIT | n/a |
EV / FCF | n/a |
Financial Position
The company has a current ratio of 31.65, with a Debt / Equity ratio of 0.01.
Current Ratio | 31.65 |
Quick Ratio | 31.53 |
Debt / Equity | 0.01 |
Debt / EBITDA | n/a |
Debt / FCF | n/a |
Interest Coverage | n/a |
Financial Efficiency
Return on Equity (ROE) | n/a |
Return on Assets (ROA) | n/a |
Return on Invested Capital (ROIC) | n/a |
Return on Capital Employed (ROCE) | -19.19% |
Revenue Per Employee | n/a |
Profits Per Employee | -$769,444 |
Employee Count | 18 |
Asset Turnover | n/a |
Inventory Turnover | n/a |
Taxes
Income Tax | n/a |
Effective Tax Rate | n/a |
Stock Price Statistics
Beta (5Y) | n/a |
52-Week Price Change | n/a |
50-Day Moving Average | n/a |
200-Day Moving Average | n/a |
Relative Strength Index (RSI) | 30.05 |
Average Volume (20 Days) | 114,965 |
Short Selling Information
The latest short interest is 332,071, so 1.22% of the outstanding shares have been sold short.
Short Interest | 332,071 |
Short Previous Month | 241,914 |
Short % of Shares Out | 1.22% |
Short % of Float | 1.84% |
Short Ratio (days to cover) | n/a |
Income Statement
Revenue | n/a |
Gross Profit | n/a |
Operating Income | -15.57M |
Pretax Income | -13.85M |
Net Income | -13.85M |
EBITDA | n/a |
EBIT | -15.57M |
Earnings Per Share (EPS) | -$3.49 |
Full Income Statement Balance Sheet
The company has $82.36 million in cash and $868,000 in debt, giving a net cash position of $81.49 million or $2.99 per share.
Cash & Cash Equivalents | 82.36M |
Total Debt | 868,000 |
Net Cash | 81.49M |
Net Cash Per Share | $2.99 |
Equity (Book Value) | 80.58M |
Book Value Per Share | -11.38 |
Working Capital | 80.05M |
Full Balance Sheet Cash Flow
In the last 12 months, operating cash flow was -$11.52 million and capital expenditures -$103,000, giving a free cash flow of -$11.62 million.
Operating Cash Flow | -11.52M |
Capital Expenditures | -103,000 |
Free Cash Flow | -11.62M |
FCF Per Share | -$0.43 |
Full Cash Flow Statement Margins
Gross Margin | n/a |
Operating Margin | n/a |
Pretax Margin | n/a |
Profit Margin | n/a |
EBITDA Margin | n/a |
EBIT Margin | n/a |
FCF Margin | n/a |